Jilin Changlong Pharmaceutical released its annual performance, with a net profit attributable to shareholders of 148 million yuan, a year-on-year decrease of 23.43%

智通財經
2024.03.29 03:30

智通財經 APP 訊，吉林長龍藥業發佈截至 2023 年 12 月 31 日止年度業績，該集團取得收入人民幣 8.42 億元 (單位下同)，同比持平;公司擁有人應占溢利 1.48 億元，同比減少 23.43%;每股盈利 26.45 分。

智通財經 APP 訊，吉林長龍藥業 (08049) 發佈截至 2023 年 12 月 31 日止年度業績，該集團取得收入人民幣 8.42 億元 (單位下同)，同比持平;公司擁有人應占溢利 1.48 億元，同比減少 23.43%;每股盈利 26.45 分。

Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.